MEDICAGO UNLEASH THE POWER OF PLANTS Trademark

Trademark Overview


On Friday, April 2, 2021, a trademark application was filed for MEDICAGO UNLEASH THE POWER OF PLANTS with the United States Patent and Trademark Office. The USPTO has given the MEDICAGO UNLEASH THE POWER OF PLANTS trademark a serial number of 90620821. The federal status of this trademark filing is REGISTERED as of Tuesday, October 11, 2022. This trademark is owned by Medicago Inc.. The MEDICAGO UNLEASH THE POWER OF PLANTS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies

Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer

Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies

Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates; Medical information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, pr...
medicago unleash the power of plants

General Information


Serial Number90620821
Word MarkMEDICAGO UNLEASH THE POWER OF PLANTS
Filing DateFriday, April 2, 2021
Status700 - REGISTERED
Status DateTuesday, October 11, 2022
Registration Number6868840
Registration DateTuesday, October 11, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements


Goods and ServicesManufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
Goods and ServicesPharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
Section 2(f) Limitation Statementas to "MEDICAGO"
Goods and ServicesMedical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
Goods and ServicesResearch and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates; Medical information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, July 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSunday, July 11, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 11, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 11, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedicago Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressQuébec (Québec) G1V3V9
CA

Party NameMedicago Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressQuébec (Québec) G1V3V9
CA

Party NameMedicago Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressQuébec (Québec) G1V3V9
CA

Trademark Events


Event DateEvent Description
Tuesday, October 11, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 11, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 23, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 22, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, June 22, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 22, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, June 22, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, June 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 2, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 2, 2022ASSIGNED TO LIE
Wednesday, May 25, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 26, 2021NON-FINAL ACTION E-MAILED
Friday, November 26, 2021NON-FINAL ACTION WRITTEN
Wednesday, November 17, 2021ASSIGNED TO EXAMINER
Sunday, July 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 6, 2021NEW APPLICATION ENTERED IN TRAM